窑Original Article窑 Angiogenesis plays an important role in tumor growth and metastasis. Although lots of growth factors take part in this process, vascular endothelial growth factor (VEGF) is the most important one. It promotes the proliferation and migration of vascular endothelial cells. Clinical data show that with high expression of VEGF, the tumor grows rapidly and the metastasis occurs earlier or more [1, 2] . Thus, blocking the expression of VEGFA is one of the effective ways to suppress tumor growth and metastasis [3] . RNA interference (RNAi) technology is a recently developed method for effectively downregulating the expression of target genes [4] .
However, how to efficiently transfer RNA interfering molecules is still a problem, which limits the application of RNAi technology in disease treatment. cells/well). Fresh media was added (1 mL/well) to replace old one on the infection day. Cells were treated with gemcitabin (final concentrations, 0.005 and 0.01 滋 g/mL), epirubicin (0.0025, 0.025, and 0.25 滋 g/mL), cisplatin (1, 2.5, and 5 滋 g/mL), 5fluorouracil (5FU, 0, 1, 5, and 10 滋 g/mL), respectively, and cultured with 5 MOI of Ad/EGFP simultaneously. The expression of GFP was recorded by fluorescence microscope after 24, 48 and 72 h. The percentage of GFPpositive cells and the average fluorescent intensity were detected by flow cytometry at 72 h after trypsin digestion. Duplicate wells were set, and the whole experiment was repeated twice.
One day before infection, LA795 cells were seeded onto 2 4well plates (8 伊 10 4 cells/well). Fresh media was added (1 mL/well) to replace old on the infection day. Cells were treated with cisplatin (1, 2.5, and 5 滋 g/mL) and 5FU (0, 1, 5, and 10 滋 g/mL), respectively, and cultured with 50 MOI of Ad/siVEGFA. Supernatants were collected after 48 h of infection. The expression of VEGFA in collected supernatants was tested by mouse VEGFA ELISA kit (R&D Co.) according to the handbook. VEGFA expression in samples without any treatment was considered as 1, and the expression of VEGFA in other wells were calculated by comparing to the control. Duplicate wells were set, and the whole experiment was repeated twice.
One day before infection, LA795 cells were seeded onto 24 well plates (8 伊 10 4 cells/well). Fresh media was added (1 mL/well) to replace old on the infection day. Cells were treated with 5FU (0, 1, 5, and 10 滋 g/mL) and 50 MOI of Ad/siVEGFA. Cells were collected after 48 h. Trizol reagent (Invitrogen) was used to extract total RNA. Total RNA (1 滋 g) was used to synthesize the first chain of cDNA by reverse transcription system (Promega). Primers of VEGFA were designed and GAPDH was used as an internal control. Realtime fluorescent polymerase chain reaction (PCR) was processed by incorporating SybrGreen in the MJ Opticon2 (BIORAD) system. The mRNA expression of VEGFA in tumor cells were calculated by C(t) values according to the formula of 2 -驻 驻 C (t) . Duplicate wells were set, and the whole experiment was repeated twice.
LA795 cells were inoculated into the right hind legs of 42 T739 mice (1 伊 10 6 cells in each mouse). After one week, the mice were divided into 7 groups (6 mice in each group): Ad/siVEGFA group (Ad/siVEGFA was injected into tumor); Ad/siVEGFA+5FU (ip) group (Ad/siVEGFA was injected into tumor and 5FU was injected into the peritoneal cavity); Ad/siVEGFA+5FU (tumor) group (both Ad/siVEGFA and 5FU were injected into tumor); 5FU (ip) group (5FU was injected into the peritoneal cavity); 5FU
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(tumor) group (5FU was injected into tumor); Ad/siNeg group (Ad/siNeg was injected into tumor) and NS group (normal saline was injected into tumor). The dosages were as follows: 1 伊 10 9 PFU (100 滋 L) of Ad/siVEGFA per mouse for intratumoral injection every two days for five times; 20 mg/kg of 5FU per mouse for intraperitoneal injection or 200 滋 g/100 滋 L per mouse for intratumoral injection every two days for five times. The longest diameter (a) and shortest diameter (b) of tumor were measured 23 times every week. According to the formula = 0.52ab 2 , the tumor volume was calculated and a growth curve of tumor was draw. After 4 weeks, animals were killed.
Statistical analysis was performed using SPSS11.0 software. Data are shown as mean 依 standard error (SE). Oneway ANOVA was used for univariate analysis of variance. < 0.05 was considered significant. Ad/siVEGFA, the percentage of GFPpositive cells was increased from (23.7 依 4.4)% to (49.5 依 2.8)% ( < 0.05) by adding 1 滋 g/mL 5FU, and it was also increased by adding 1 滋 g/mL cisplatin. With the increasing concentrations of drugs, the infection efficiency of Ad/siVEGFA was decreased, which was thought to be caused by the increasing killing effect of drugs on cells. (Figure 4) , indicating that early application of chemotherapeutic drugs had inhibitory effect on tumor growth, but showed no longterm effect after withdrawing the drugs. Ad/siVEGFA alone suppressed tumor growth, but also showed no longterm effect. The combination of adenovirus and 5FU suppressed tumor growth for longterm.
VEGFA induces the activation and expression of a series of downstream factors by binding with its receptor and enhances tumor growth and metastasis, and is an important pathway in the center of a network composed of many angiogenesisrelated factors [5] . Clinical studies and animal experiments showed that the expression of VEGFA in tumor or serum was positively correlated to tumor growth, metastasis, and prognosis [6] . Currently, blocking VEGF signaling pathway has become an important strategy for tumor treatment [7] . We also validated that blocking VEGF expression could effectively suppress intratumoral angiogenesis, vascular leak, tumor growth and metastasis, and extend the survival time of tumorbearing mice [3, 8] . RNAi is a widely existent, sequencespecific posttranscriptional gene silencing phenomenon mediated by double chains of RNA, which supplies a revolutionary tool for studying gene function and gene therapy. Double chains of RNA were degraded into small interfering RNA (siRNA) with 2123 nucleotides by nuclease Dicer. Unwound siRNA recognizes and degrades homologous mRNA by base pairing, which is a feedback amplification process degrading mRNA completely and rapidly once started and resulting gene suppressing [4袁911] . RNAi has been more and more applied in tumor gene therapy by downregulating the expression of tumor growth and metastasisrelated genes to suppress tumor growth and metastasis, and is expected to be applied in clinical treatment [1214] . We have used adenovirusmediated siRNA against E2F1 to inhibit RB tumor growth in the anterior chamber of eye in nude mice [15] . It has been reported that the expression of VEGF was reduced in nude mice with tumors formed by osteosarcoma cell line MG63 through AdVEGFsiRNA infection, which was used to treat osteosarcoma [16] . Chemotherapy is an important means for clinical tumor treatment currently. By acting on different stages of cell proliferation, chemotherapeutic drugs suppress or kill tumor cells. However, chemotherapeutic drugs also have strong toxicity on normal cells, causing severe damage on patients. 5FU is a widely used chemotherapeutic drug in clinical tumor treatment, and the main mechanism is that through simulating the chemical structure of normal metabolic products, such as folic acid, purine base and pyrimidine base, it counters the metabolic substance in S phase of cell cycle, thus interferes the synthesis of nucleic acid, especially DNA, to inhibit tumor cell division and proliferation.
Recently, more and more researches applied combination of chemotherapeutic drugs and adenovirus vector to treat various types of tumors and received great curative effect [17, 18] . In this study, we explored the effects of different chemotherapeutic drugs on the infection efficiency of adenovirus in mouse lung carcinoma LA795 cells, and found that low dose of 5FU significantly enhanced the infection efficiency of Ad/VEGFA and the expression of VEGFA. Based on this result, we constructed a VEGFA siRNA adenovirus vector, by combining with low dose of 5FU, VEGFA siRNA adenovirus vector significantly elevated the ability of adenovirus to downregulate both RNA and protein expression of VEGFA. In addition, the combination obviously suppressed tumor growth in vivo comparing with control group. This strategy not only increased the curative effect but also decreased the dosage of drugs, reduced the toxicity induced by chemotherapeutic drugs, enhanced the expression efficiency of exogenous gene mediated by adenovirus vector, and improved the inhibitory effect of adenovirus on tumor growth. Combination of chemotherapeutic drugs and adenovirus vector has specific advantage and prospect on patients at advanced stages and not adapt to surgical operation.
